AV8 Ventures is an Allianz-backed early-stage venture capital firm based in Palo Alto, California. The firm invests in pre-seed, seed, and Series A startups with selective follow-on participation in Series B, focusing on healthcare, enterprise software, financial services, and deep technology.
Average disclosed round size is $29.6M (across 41 rounds with reported amounts).
Portfolio
26
Fund Size
$360M
Top Stage
Series A
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
45 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Think Bioscience | Series A | $55M | Jan 2026 |
 Hydrolix | Series C | $80M | Apr 2025 |
 Cerby | Series A | $17M | Aug 2023 |
 DataGalaxy | Seed | $10M | Jan 2023 |
 Axuall | Series B | $20M | Jan 2023 |
 Glow | Series A | $22.5M | Nov 2022 |
 CoverTree | Seed | $10M | Sep 2022 |
| Think Bioscience | Seed | $17M | Aug 2022 |
 Delfi Diagnostics, Inc. | Series B | — | Jul 2022 |
 Delfi | Series B | — | Jul 2022 |
 WAX Insurance Services | Seed | $10M | May 2022 |
 Soter Analytics | Series A | $12M | Jan 2022 |
| Delfi | Series B | $225M | Jan 2022 |
| SSoter | Series A | $12M | Jan 2022 |
 Soter Analytics | Series A | $12M | Jan 2022 |
 Yuvo Health | Seed | $7.3M | Jan 2022 |
 Eclypsium, Inc | Series B | $25M | Jan 2022 |
 Embrace | Series B | $45M | Oct 2021 |
| AAlpha Medical | Series B | $24M | Sep 2021 |
 Uizard | Series A | $15M | Aug 2021 |
| Axuall | Series A | $10.4M | Jul 2021 |
 Elucidate | Series A | $3.0M | Mar 2021 |
| Hydrolix | Seed | $10M | Feb 2021 |
| Delfi Diagnostics, Inc. | Series A | $100M | Jan 2021 |
| Delfi | Series A | $100M | Jan 2021 |
Page 1 of 2
Top Co-Investors
Illumina Ventures9 shared
Menlo Ventures9 shared
Windham Capital Partners9 shared
Samsara BioCapital9 shared
Northpond Ventures7 shared
Cowen Healthcare Investments6 shared
T. Rowe Price6 shared
OrbiMed6 shared
Foresite Capital6 shared
Rock Springs Capital6 shared
Greycroft5 shared
Eniac Ventures4 shared
Oregon Venture Fund4 shared
Open Field Capital4 shared
Osage University Partners4 shared
Eli Lilly and Company4 shared
New Enterprise Associates3 shared
Founders Fund3 shared
QED Investors3 shared
S3 Ventures3 shared
Last updated: 7 October 2026